Genetic and Immunological Profiling of Recent SARS-CoV-2 Omicron Subvariants: Insights into Immune Evasion and Infectivity in Monoinfections and Coinfections

The evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its impact on public health continue to demand attention as the virus continues to evolve, demonstrating a remarkable ability to adapt to diverse selective pressures including immune responses, therapeutic treatmen...

Full description

Saved in:
Bibliographic Details
Main Authors: Nadine Alvarez, Irene Gonzalez-Jimenez, Risha Rasheed, Kira Goldgirsh, Steven Park, David S. Perlin
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/17/7/918
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850071473321934848
author Nadine Alvarez
Irene Gonzalez-Jimenez
Risha Rasheed
Kira Goldgirsh
Steven Park
David S. Perlin
author_facet Nadine Alvarez
Irene Gonzalez-Jimenez
Risha Rasheed
Kira Goldgirsh
Steven Park
David S. Perlin
author_sort Nadine Alvarez
collection DOAJ
description The evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its impact on public health continue to demand attention as the virus continues to evolve, demonstrating a remarkable ability to adapt to diverse selective pressures including immune responses, therapeutic treatments, and prophylactic interventions. The SARS-CoV-2 variant landscape remains dynamic, with new subvariants continuously emerging, many harboring spike protein mutations linked to immune evasion. In this study, we characterized a panel of live SARS-CoV-2 strains, including those key subvariants implicated in recent waves of infection. Our findings revealed a significant variability in mutation patterns in the spike protein across the strains analyzed. Commercial antibodies and human convalescent plasma (HCoP) samples from unvaccinated donors were ineffective in neutralizing the most recent Omicron subvariants, particularly after the emergence of JN.1 subvariant. Using human airway epithelial cells derived from healthy bronchiolar tissue (hBAEC), we established both monoinfections and coinfections involving SARS-CoV-2, Influenza A virus H1N1 (IFAV_H1N1) and Respiratory Syncytial Virus (RSV). Assessments were conducted to compare viral infectivity and the production and release of immune mediators in the apical and basolateral compartments. Notably, Omicron KP.3.1.1 subvariant induced a more pronounced cytopathic effect in hBAEC compared to its parental strain JN.1 and even surpassed the impact observed with the ancestral wild-type virus (WA1/2020, Washington strain). Furthermore, the coinfection of KP.3.1.1 subvariant with IFAV_H1N1 or RSV did not attenuate SARS-CoV-2 infectivity; instead, it significantly exacerbated the pathogenic synergy in the lung epithelium. Our study demonstrated that pro-inflammatory cytokines IL-6, IFN-β, and IL-10 were upregulated in hBAEC following SARS-CoV-2 monoinfection with recent Omicron subvariants as well as during coinfection with IFAV_H1N1 and RSV. Taken together, our findings offer new insights into the immune evasion strategies and pathogenic potential of evolving SARS-CoV-2 Omicron subvariants, as well as their interactions with other respiratory viruses, carrying important implications for therapeutic development and public health preparedness.
format Article
id doaj-art-395f181ad99c43369ffd03c1d1c8dae3
institution DOAJ
issn 1999-4915
language English
publishDate 2025-06-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj-art-395f181ad99c43369ffd03c1d1c8dae32025-08-20T02:47:18ZengMDPI AGViruses1999-49152025-06-0117791810.3390/v17070918Genetic and Immunological Profiling of Recent SARS-CoV-2 Omicron Subvariants: Insights into Immune Evasion and Infectivity in Monoinfections and CoinfectionsNadine Alvarez0Irene Gonzalez-Jimenez1Risha Rasheed2Kira Goldgirsh3Steven Park4David S. Perlin5Center for Discovery and Innovation, Hackensack Meridian Health, 111 Ideation Way, Nutley, NJ 07110, USACenter for Discovery and Innovation, Hackensack Meridian Health, 111 Ideation Way, Nutley, NJ 07110, USACenter for Discovery and Innovation, Hackensack Meridian Health, 111 Ideation Way, Nutley, NJ 07110, USACenter for Discovery and Innovation, Hackensack Meridian Health, 111 Ideation Way, Nutley, NJ 07110, USACenter for Discovery and Innovation, Hackensack Meridian Health, 111 Ideation Way, Nutley, NJ 07110, USACenter for Discovery and Innovation, Hackensack Meridian Health, 111 Ideation Way, Nutley, NJ 07110, USAThe evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its impact on public health continue to demand attention as the virus continues to evolve, demonstrating a remarkable ability to adapt to diverse selective pressures including immune responses, therapeutic treatments, and prophylactic interventions. The SARS-CoV-2 variant landscape remains dynamic, with new subvariants continuously emerging, many harboring spike protein mutations linked to immune evasion. In this study, we characterized a panel of live SARS-CoV-2 strains, including those key subvariants implicated in recent waves of infection. Our findings revealed a significant variability in mutation patterns in the spike protein across the strains analyzed. Commercial antibodies and human convalescent plasma (HCoP) samples from unvaccinated donors were ineffective in neutralizing the most recent Omicron subvariants, particularly after the emergence of JN.1 subvariant. Using human airway epithelial cells derived from healthy bronchiolar tissue (hBAEC), we established both monoinfections and coinfections involving SARS-CoV-2, Influenza A virus H1N1 (IFAV_H1N1) and Respiratory Syncytial Virus (RSV). Assessments were conducted to compare viral infectivity and the production and release of immune mediators in the apical and basolateral compartments. Notably, Omicron KP.3.1.1 subvariant induced a more pronounced cytopathic effect in hBAEC compared to its parental strain JN.1 and even surpassed the impact observed with the ancestral wild-type virus (WA1/2020, Washington strain). Furthermore, the coinfection of KP.3.1.1 subvariant with IFAV_H1N1 or RSV did not attenuate SARS-CoV-2 infectivity; instead, it significantly exacerbated the pathogenic synergy in the lung epithelium. Our study demonstrated that pro-inflammatory cytokines IL-6, IFN-β, and IL-10 were upregulated in hBAEC following SARS-CoV-2 monoinfection with recent Omicron subvariants as well as during coinfection with IFAV_H1N1 and RSV. Taken together, our findings offer new insights into the immune evasion strategies and pathogenic potential of evolving SARS-CoV-2 Omicron subvariants, as well as their interactions with other respiratory viruses, carrying important implications for therapeutic development and public health preparedness.https://www.mdpi.com/1999-4915/17/7/918SARS-CoV-2Omicronrespiratory virusesneutralizationhuman bronchial airway epithelial cellsALI model
spellingShingle Nadine Alvarez
Irene Gonzalez-Jimenez
Risha Rasheed
Kira Goldgirsh
Steven Park
David S. Perlin
Genetic and Immunological Profiling of Recent SARS-CoV-2 Omicron Subvariants: Insights into Immune Evasion and Infectivity in Monoinfections and Coinfections
Viruses
SARS-CoV-2
Omicron
respiratory viruses
neutralization
human bronchial airway epithelial cells
ALI model
title Genetic and Immunological Profiling of Recent SARS-CoV-2 Omicron Subvariants: Insights into Immune Evasion and Infectivity in Monoinfections and Coinfections
title_full Genetic and Immunological Profiling of Recent SARS-CoV-2 Omicron Subvariants: Insights into Immune Evasion and Infectivity in Monoinfections and Coinfections
title_fullStr Genetic and Immunological Profiling of Recent SARS-CoV-2 Omicron Subvariants: Insights into Immune Evasion and Infectivity in Monoinfections and Coinfections
title_full_unstemmed Genetic and Immunological Profiling of Recent SARS-CoV-2 Omicron Subvariants: Insights into Immune Evasion and Infectivity in Monoinfections and Coinfections
title_short Genetic and Immunological Profiling of Recent SARS-CoV-2 Omicron Subvariants: Insights into Immune Evasion and Infectivity in Monoinfections and Coinfections
title_sort genetic and immunological profiling of recent sars cov 2 omicron subvariants insights into immune evasion and infectivity in monoinfections and coinfections
topic SARS-CoV-2
Omicron
respiratory viruses
neutralization
human bronchial airway epithelial cells
ALI model
url https://www.mdpi.com/1999-4915/17/7/918
work_keys_str_mv AT nadinealvarez geneticandimmunologicalprofilingofrecentsarscov2omicronsubvariantsinsightsintoimmuneevasionandinfectivityinmonoinfectionsandcoinfections
AT irenegonzalezjimenez geneticandimmunologicalprofilingofrecentsarscov2omicronsubvariantsinsightsintoimmuneevasionandinfectivityinmonoinfectionsandcoinfections
AT risharasheed geneticandimmunologicalprofilingofrecentsarscov2omicronsubvariantsinsightsintoimmuneevasionandinfectivityinmonoinfectionsandcoinfections
AT kiragoldgirsh geneticandimmunologicalprofilingofrecentsarscov2omicronsubvariantsinsightsintoimmuneevasionandinfectivityinmonoinfectionsandcoinfections
AT stevenpark geneticandimmunologicalprofilingofrecentsarscov2omicronsubvariantsinsightsintoimmuneevasionandinfectivityinmonoinfectionsandcoinfections
AT davidsperlin geneticandimmunologicalprofilingofrecentsarscov2omicronsubvariantsinsightsintoimmuneevasionandinfectivityinmonoinfectionsandcoinfections